A Study of the Comparative Bioavailability of Two Second-Generation Investigational Pediatric Oral Granule Formulations of MK-1439 Compared to the Adult Formulation. Additional PIP decision number: P/139/2016

Trial Profile

A Study of the Comparative Bioavailability of Two Second-Generation Investigational Pediatric Oral Granule Formulations of MK-1439 Compared to the Adult Formulation. Additional PIP decision number: P/139/2016

Not stated
Phase of Trial: Phase I

Latest Information Update: 22 Nov 2016

At a glance

  • Drugs Doravirine (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Acronyms MK-1439 Mini-Tab Study
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 22 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top